1/40
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
Orthomyxoviridae
ssRNA, enveloped, helical
3 major antigenic types: A,B,C
MATRIX protein (M) AND Nucleoprotein (NP)
Types A & B cause nearly all human disease
Influenza A
8 segments
MOT: contact with respiratory secretions
DISEASE AND DIAGNOSIS:
Influenza (fever,malaise,headache,myalgia,cough)
PRIMARY INFLUENZA PNEUMONIA
children:
bronchiolitis,croup,otitis media
DIAGNOSIS: cell culture(PMK,MDCK). EIA,FA stain,RT-PCR,rapid test kit
TREATMENT: SUPPORTIVE,
antivirals:
amantadine rimantadine (for influenza A) oseltamivir
Neuraminidase inhibitors for Influenza A & B)
PREVENTION: influenza vaccine or antiviral prophylaxis
Influenza B
8 segments
MOT: contact with respiratory secretions
DISEASE: mild influenza
TREATMENT: SUPPORTIVE,
antivirals: zanamivir oseltamivir
PREVENTION: influenza vaccine or antiviral prophylaxis
Influenza C
7 segments
MOT: contact with respiratory secretions
seasonal flu - mild form of influenza causing URTIs
DIAGNOSIS:
testing is not routinely requested, the virus is infrequently detected: only valid test NAAT
hemagglutination
(H1-H16)
adsorption and attachment
Neuraminidase
(N1-N9)
penetration and budding
antigen variation
antigenic drift
antigenic shift
strains
antigenic drift
minor change in antigenic structure
occurs in point mutations in the viral genes encoding the HA & NA spikes. It can also occur within any of three influenza viruses and may cause Local (epidemics) INFLUENZA OUTBREAK
antigenic shift
drastic change in antigenic structure
RESULTS to new H and N antigens. may cause (epidemics) and epidemic and pandemics (occurs to Influenza A only)
mechanisms of antigenic shift
genetic reassortment
adaptive mutation
genetic reassortment
genomes of different influenza viruses combine into single virion, resulting new strain of influenza virus
adaptive mutation
novel virus slowly adjusts and becomes transmissible form mammalian (including human) host
Strains
H1N1 - spanish flu, swine flu, bird flu (1918-1919)
H2N2 - asian flu (1957-1958)
H3N2 - hongkong flu (1968)
H5N1 - avian flu (HPAI) highly pathogenic avian influenza
H7N9 - novel avian flu (china) *predominant strain
H1N1
spanish flu, swine flu, bird flu (1918-1919)
H2N2
asian flu (1957-1958)
H3N2
hongkong flu (1968)
H5N1
avian flu (HPAI) highly pathogenic avian influenza
H7N9
novel avian flu (china) *predominant strain
rna segments
A- 8 segments
B- 8 segments
C - 7 segments
antigenic drift
A- +
B- +
C-+
antigenic shift
A- +
B- (-)
C- (-)
hemagglutination
A- +
B- +
C- +
neuraminidase
A- +
B-+
C- (-)
Paramyxoviridae
ssRNA, enveloped, helical with no segment genome
measles rubeola
kopliks spots (buccal cavity)
MOT: Contact with respiratory
secretions; extremely contagious
titer of ab: low
DISEASE
measles atypical measles (occurs in waning vaccine immunity)
subacutesclerosing panencephalitis
DIAGNOSIS:
cell culture (PMK) and serology
TREATMENT:
Supportive; immunocompromised patients can be treated with immune serum globulin
PREVENTION: measles vaccine
mumps virus
MOT: person-to-person-contact
respiratory droplet infected saliva
DISEASE:
mumps (unilateral/bilateral) swelling of the glands; other glands (testes, ovaries and pancreas)
TREATMENT:
supportive
Prevention: mumps vaccine
PIV-14 (parainfluenza virus)
PIV 1 (more often)
PIV 1-2 - (serious disease in children)
MOT: contact with respiratory secretions
DISEASE: adults:supper respiratory disease, rarely pneumonia
children: respiratory including croup (laryotracheobronchitis) bronchiolitis and pneumonia
DIAGNOSIS:
cell culture (PMK), shell vial culture, IF stain (rapid)
TREATMENT:
supportive; aerolized ribavirin
PREVENTION:
avoid contact with virus
virulence factors
hemagglutination - neuraminidase (HN) - viral adhesion molecule
Fusion (f) antigen - fusion of virus to the cell and one infected cell to another infected cell
RSV (Respiratory Syncytial Virus
MOT: Person to person by hand and respiratory contact (large particle droplet)
DISEASE:
Primarily in infants and children.
Infants: bronchiolitis,pneumonia and croup
Children: upper respiratory disease
Diagnosis: Cell culture, (Hep-2), EIA and FA stain
TREATMENT:
supportive; treat severe disease compromised infects
with ribavirin; MAB palivizumab (blocks RSV entry into the host cell)
PREVENTION:
Avoid contact with viruses; immune globulin for infants with underlying lung disease
Human metapnemovirus (HMPV)
MOT: Person-to person
DISEASE: Primarily in infants and children;
bronchiolitis and pneumonia
DIAGNOSIS:
RT-PCR
EPIDEMIOLOGY:
winter epidemics varies year to year
TREATMENT:
Supportive
PREVNTION:
Avoid contact with virus
RSV (Respiratory Syncytial Virus)
MOT: Person to person by hand and respiratory contact (large particle droplet)
DISEASE:
Primarily in infants and children.
Infants: bronchiolitis,pneumonia and croup
Children: upper respiratory disease
Diagnosis: Cell culture, (Hep-2), EIA and FA stain
Human metapnemovirus (HMPV)
MOT: Person-to person
DISEASE: Primarily in infants and children;
bronchiolitis and pneumonia
DIAGNOSIS:
RT-PCR
EPIDEMIOLOGY:
winter epidemics varies year to year
F protein
causes infected cells to fuse form of syncytia
Picornaviridae
ssRNA,naked,icosahedral (largest)
VIRUS AND CHARCATERISTICS
enteroviruses 73 to 120
rhinoviruses A to C
polioviruses 1 to 3
coxsackieviruses A1 to A24
coxsackieviruses B1 to B6
echoviruses l to 33
MOT: Fecal-oral - route ( polio)
aerosol and inahalation fomites ( coxsackieviruse A & B, Enterovirus and echinovirus)
enteroviruses
73 to 120
rhinoviruses
A to C
polioviruses
1 to 3
coxsackieviruses
A1 to A24
B1 to B6
echinovirus
1 to 33 / l to 33
diseases of picornaviridae
poliovirus: polio
Coxsackie A: herpangina, HFMD ( Hand-foot - mouth - disease)
Coxsackie B: pleurodynia,pericarditis,myocarditis
Echovirus: congenital and neonatal disease,myocarditis/pericarditis,febrile illness with ras,meningitis
Enterovirus 70: conjunctivitis
TREATMENT:
supportive,pleconaril
PREVENTION:
Avoid contact with viruses, vaccination for polio
HEPA A VIRUS (enterovirus type 72)
MOT: fecal oral route
DISEASE:
Hepatitis with short incubation, abrupt onset, low mortality, no carrier state
HEPATITIS B (long incubation carrier state)
DIAGNOSIS: serology
TREATMENT: supportive
PREVENTION: Vaccine; prevent clinical
illness with serum immunoglobulin
rhinovirus
150 serotypes
common cold
labile (nose) vs entero-stable(mouth)
-aseptic - causes aspetic meningitis
meningitis - summer flu (+)
- summer flu (-)
MOT: aerosols, contact with secretions and fomites
DISEASE: common cold
DIAGNOSIS: cell culture not necessary
RT-PCR
TREATMENT: supportive
PREVENTION: Avoid contact with
viruses
Reoviridae
dsRNA, naked, icosahedral
MOT:fecal-oral route,foodborne,waterborne
DISEASE: gastroenteritis in infants and young children